Publications

Found 6 results

Filters: Author is Dahmane, Nadia [Clear All Filters]

Journal Article

Maachani UB, Tosi U, Pisapia DJ, Mukherjee S, Marnell CS, Voronina J, Martinez D, Santi M, Dahmane N, Zhou Z et al.. 2019. B7-H3 As a Prognostic Biomarker and Therapeutic Target in Pediatric Central Nervous System Tumors. Transl Oncol. 13(2):365-371.

Martinez-Lage M, Lynch TM, Bi Y, Cocito C, Way GP, Pal S, Haller J, Yan RE, Ziober A, Nguyen A et al.. 2019. Immune landscapes associated with different glioblastoma molecular subtypes.. Acta Neuropathol Commun. 7(1):203.

Taha B, Winston G, Tosi U, Hartley B, Hoffman C, Dahmane N, Mason CE, Greenfield JP. 2020. Missing diversity in brain tumor trials.. Neurooncol Adv. 2(1):vdaa059.

Tosi U, Kommidi H, Adeuyan O, Guo H, Maachani UBhanu, Chen N, Su T, Zhang G, Pisapia DJ, Dahmane N et al.. 2020. PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models.. Sci Adv. 6(30):eabb4105.

Martin B, Garman T, Laramee M, Wang A, Zhang X, Beck E, Wilson K, Klumpp-Thomas C, McKnight C, Xu X et al.. 2023. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma. J Control Release. 357:580-590.

Xiang C, Frietze KK, Bi Y, Li Y, Dal Pozzo V, Pal S, Alexander N, Baubet V, D'Acunto V, Mason CE et al.. 2021. RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing Neurons.. Mol Cell Biol. 41(7):e0052620.